Agent Capital
Mr. R. John Glasspool serves as a Venture Partner at Agent Capital, LLC, and has over 25 years of deep commercial industry expertise throughout the BioPharma industry. John was former Executive Vice President and Head of Corporate Strategy & Commercial Operations at Baxalta from 2015 to 2017. He served as Vice President, Head of Emerging Therapies and Market Development of Baxter International’s Bioscience division from 2012 to 2015. From 2002 to 2012, John served at Novartis where he was Head of Region Europe for Vaccines and Diagnosis; Global Head Pharma Commercial Operations, Pricing and Market Access; and Head of Cardiovascular and Neuroscience Franchises. From 1991 to 2002, John served at Johnson & Johnson where he had roles of increasing responsibility within the Sales and Marketing division, including as Director of Strategic Marketing.
This person is not in any offices
Agent Capital
Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Their investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. They make direct equity investments across all stages of development and types of financing rounds.